On May 17, 2025, a leading shareholder rights firm, Julie & Holleman LLP, is conducting an inquiry into possible lawsuits against Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) and its management due to the recent decline in the company's stock value. The investigation aims to support stockholders who have incurred losses. Those interested in a no-cost consultation...